The manufacturing of personalized medicine occupies an imperative place in the spectrum of innovation and scale associated with the development of new adaptive cell and gene therapies. Increase of more personalized and bespoke treatments, to manufacture custom, individualized cell products in a way that is consistent, high-quality, regulatory-compliant, and can be scaled up and out to commercial levels.
The Cell and gene therapy meeting will provide a unique insight into these considerations and how they relate to next-generation technologies, process innovations, and consider ongoing and future manufacturing visionary practices - ensuring that bespoke, individually manufactured high-quality cell therapies.